SAN JOSE, Calif. — A quantum computing startup said Tuesday it had demonstrated a sustained error-correction rate that researchers say could make commercially useful quantum processors viable within three to five years, potentially compressing a timeline that industry forecasters had pegged at a decade or more.
Helix Quantum Technologies, founded in 2019 and backed by roughly $1.2 billion in venture and corporate investment, published findings in the peer-reviewed journal Quantum Systems showing its 512-qubit processor maintained logical error rates below one in ten million operations across a 48-hour continuous run — a threshold widely cited in the field as necessary for fault-tolerant computation that could outperform classical supercomputers on real-world problems.
“This is not a demonstration under ideal lab conditions for a few minutes,” said Dr. Priya Sundaram, Helix’s chief science officer and lead author of the paper. “We ran it continuously for two days under conditions designed to simulate the thermal and electromagnetic noise of a real operating environment. The error rates held across the full duration, and we saw no degradation trend.”
Independent researchers who reviewed the paper before publication called the results significant but urged measured expectations. “If the methodology holds up to broad replication, this is a meaningful step forward,” said Professor Luca Ferrante of the Institute for Advanced Computation in Turin. “But quantum computing has a long history of results that prove harder to generalize than the initial announcement suggests. We will want to see this architecture running on diverse problem classes.”
The error-correction technique Helix developed, which the company has branded as Cascade Parity Architecture, uses a novel arrangement of ancilla qubits to detect and compensate for decoherence events in real time without collapsing the quantum state of the primary computational qubits. The company said the design reduces the overhead qubit count required for error correction by approximately 40 percent compared with leading competing approaches, which translates directly into more computational capacity at a given hardware cost. Helix filed 34 related patents in 2024 and 2025.
Helix said it has already signed memoranda of understanding with two pharmaceutical companies and one logistics firm to begin exploratory pilot programs in the first half of next year. The pharmaceutical partners are interested in molecular simulation for early-stage drug discovery — a domain in which quantum processors are theorized to offer substantial speed advantages — while the logistics company is evaluating complex route-optimization problems that classical computers handle inefficiently at scale.
Shares in publicly traded quantum computing companies rose between 4 and 11 percent in after-hours trading following the announcement, though analysts noted that most listed quantum firms are architecturally distinct from Helix and may not benefit directly from its specific approach.
The announcement comes amid intensifying global competition in quantum research. Government-backed programs in Europe, East Asia and North America have collectively committed more than $80 billion in public funding to quantum technologies over the past five years, reflecting strategic concern that sufficiently powerful quantum processors could eventually threaten widely used encryption standards and reshape fields from materials science to financial modeling.
Helix said it plans to make limited cloud access to its processors available to vetted research institutions by the first quarter of next year, with a broader commercial offering to follow if the pilot programs yield favorable results. The company declined to provide specific pricing details for the commercial tier, saying only that it would be structured to allow academic access at subsidized rates.
The paper will undergo additional independent peer review, and several university laboratories said they planned to attempt replication of the core results over the coming months. Sundaram said Helix welcomes the scrutiny. “Science advances through replication, not press releases,” she said. “We are confident in what we have built, and we want the community to verify that confidence.”